Description Module

Description Module

The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.

Description Module path is as follows:

Study -> Protocol Section -> Description Module

Description Module


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2025-12-24 @ 9:58 PM
NCT ID: NCT00524732
Brief Summary: To compare the reactogenicity of ADACELĀ® vaccine given at intervals of 2 to 9 years with the reactogenicity of ADACELĀ® vaccine given at an interval of 10 or more years following the last previous administration of vaccine containing Diphtheria and Tetanus Toxoids (referred to as TD/Td).
Study: NCT00524732
Study Brief:
Protocol Section: NCT00524732